Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Argent Biopharma ( (AU:RGT) ) just unveiled an update.
Argent Biopharma Limited has announced a proposed issue of 25 million ordinary fully paid securities, with the issuance date set for October 14, 2025. This move is part of a placement or other type of issue, aimed at enhancing the company’s capital structure and potentially expanding its market presence.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange (ASX) under the issuer code RGT.
Average Trading Volume: 52,294
Technical Sentiment Signal: Sell
Current Market Cap: A$4.94M
For a thorough assessment of RGT stock, go to TipRanks’ Stock Analysis page.